Sentynl is seeking pharmaceutical licensing and acquisition opportunities within the specialty pharmaceutical and rare disease space. Target acquisition opportunities include late-stage development programs and currently marketed specialty products. Please contact us to explore partnership and licensing opportunities.
For general inquiries, please visit our Contact page.
Why Partner With Sentynl Therapeutics, Inc.?
- Track record of successful partnerships, with demonstrated value creation for partners
- Founded by industry veterans with deep expertise, strategic vision, and operational excellence
- Strong financial backing and ability to move quickly to execute transactions
